Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN
Links shared publicly online about this topic.
- 354total visits
Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN
Biogen Idec (NASDAQ: BIIB) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVO
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis Medication, Healthy Living, Avonex, Biogen Idec, Medical
Most Recently Shared on April 20, 2011 at 5:54 pm By:
Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN: Biogen I... http://bit.ly/fcFtN2
Also Shared By:
Advertisement
MNT Multiple Scl
@mnt_multiplescl
Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN http://mnt.to/3TPF #multiplesclerosis
1 year ago...